{"gene":"UBP1","run_date":"2026-04-28T21:43:00","timeline":{"discoveries":[{"year":1991,"finding":"LBP-1 (encompassing LBP-1a/UBP1) is a cellular DNA-binding protein that represses HIV-1 transcription in vitro by binding to a site (site II) overlapping the TATA element, thereby inhibiting TFIID binding. Pre-binding of TFIID blocks this repression. Mutations eliminating LBP-1 binding to site II abolished in vitro repression and increased HIV-1 transcription in stably transformed cells, demonstrating a direct mechanistic role in transcriptional repression resembling bacterial repressors.","method":"In vitro transcription assay, gel mobility shift, DNase I footprinting, site-directed mutagenesis, stable cell transfection","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis and cellular validation; multiple orthogonal methods","pmids":["2006421"],"is_preprint":false},{"year":1994,"finding":"Four LBP-1 isoforms (LBP-1a, -b, -c, -d) encoded by two related genes via alternative splicing were characterized. LBP-1a (UBP1) and other isoforms bind DNA as multimers with identical specificity to native LBP-1, and specifically repress HIV-1 transcription in a cell-free system. One isoform lacking the Elf-1/NTF-1 homology region cannot bind DNA but acts as a dominant negative regulator by inhibiting other LBP-1 isoforms through heteromer formation. LBP-1 can also function as a transcriptional activator in a promoter-context-dependent manner both in vivo and in vitro.","method":"cDNA cloning, recombinant protein expression, DNA-binding assays, cell-free transcription system, in vivo reporter assays, antisera recognition","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including in vitro transcription, DNA binding, and in vivo assays; single lab but comprehensive","pmids":["8114710"],"is_preprint":false},{"year":2000,"finding":"LBP-1b and a newly identified related factor LBP-9 (sharing 83% amino acid identity with LBP-1b) both bind specifically to the -155/-131 region of the human P450scc (CYP11A1) promoter, which drives placental but not adrenal transcription. LBP-1b strongly activates P450scc transcription (21-fold) while LBP-9 suppresses this LBP-1b-mediated activation, demonstrating antagonistic roles of LBP family members in placental steroidogenesis.","method":"Yeast one-hybrid screen, yeast two-hybrid binding assay, RT-PCR, transient transfection reporter assays, antibody supershift","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal binding and functional reporter assays; single lab with multiple methods","pmids":["10644752"],"is_preprint":false},{"year":2004,"finding":"Mice lacking LBP-1a (UBP1) develop intrauterine growth retardation by embryonic day 10.5 and die by E11.5, with a pronounced defect in extraembryonic angiogenesis: allantoic blood vessels fail to branch into the placental labyrinth, and yolk sac primary capillary tubes fail to connect into a vascular network. Tetraploid complementation excluded a primary trophoblast defect, placing the angiogenic defect as the primary cause of embryonic lethality.","method":"Conditional knockout mouse model, histology, immunohistochemistry, tetraploid complementation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined lethal phenotype, complementation experiments, multiple orthogonal readouts","pmids":["15282311"],"is_preprint":false},{"year":2004,"finding":"NF2d9 (LBP-1a/UBP1), a transcription factor related to CP2/LBP-1c, binds directly to PREX (positive regulatory element for the xenobiotic responsive element) in the CYP2A8 gene and also interacts indirectly with XRE. Overexpression of NF2d9 enhances PREX- and XRE-driven CYP2A8 gene transcriptional induction.","method":"Gel mobility shift assay (EMSA), luciferase reporter gene assay, transient transfection","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct DNA binding demonstrated by EMSA plus functional reporter assay; single lab","pmids":["15716014"],"is_preprint":false},{"year":2005,"finding":"LBP-1a (UBP1) and LBP-1c are exclusively localized in the cytosol when expressed alone, whereas LBP-1b (which contains a nuclear localization signal encoded by exon 6) resides in the nucleus. Co-expression of LBP-1b with LBP-1a or LBP-1c enables nuclear transport of the latter, demonstrating that heterodimerization with LBP-1b is required for nuclear localization of UBP1/LBP-1a. In the nucleus, LBP-1 proteins form speckles that largely overlap with PML bodies, and the N-terminal region of LBP-1a mediates PML body accumulation.","method":"YFP fusion protein subcellular localization imaging in COS-7 cells, co-expression experiments, NLS mapping","journal":"Genes to cells","confidence":"Medium","confidence_rationale":"Tier 2 — direct live-cell imaging with functional consequence (nuclear entry dependent on heterodimerization); single lab","pmids":["16115195"],"is_preprint":false},{"year":2009,"finding":"LBP-1a (UBP1) is the predominant LBP/LSF family member expressed in B lymphocytes. ChIP analysis demonstrates that LBP-1a binds genomic sequences around the immunoglobulin switch regions Smu and Salpha (but not Sgamma1) in an isotype-specific manner in primary mouse splenic B cells, and this binding is dynamically regulated (occupancy decreases after LPS stimulation). Using bone marrow chimeric mice with inhibited LSF/LBP-1 activity in hematopoietic lineages, CSR to IgA (but not IgG1) was enhanced, demonstrating that LBP-1a directly represses class switch recombination in an isotype-specific manner.","method":"Chromatin immunoprecipitation (ChIP), bone marrow chimeric mouse model, in vitro B cell stimulation, CSR analysis","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — ChIP showing direct genomic occupancy, complemented by in vivo loss-of-function with isotype-specific phenotypic readout","pmids":["19384868"],"is_preprint":false},{"year":2009,"finding":"The UBP1 locus was identified as a blood pressure determinant in mice and humans. UBP1 plays a role in cholesterol and steroid metabolism through transcriptional activation of CYP11A (the rate-limiting enzyme in pregnenolone and aldosterone biosynthesis), implicating UBP1 and its functional partners in a network controlling blood pressure.","method":"QTL mapping in BXD recombinant inbred mouse strains, human genetic association study (SNP analysis), functional annotation of CYP11A transcriptional regulation","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2–3 — genetic mapping combined with prior functional data on CYP11A transcriptional activation; mechanistic link inferred rather than directly demonstrated in this paper","pmids":["19662162"],"is_preprint":false},{"year":2025,"finding":"MED16, a Mediator subunit, dissociates from the core Mediator complex to form a subcomplex with transcription factors UBP1 and TFCP2. This MED16-UBP1 interaction modulates transcription in a context-dependent (dual) manner: it activates genes involved in lung homeostasis, angiogenesis, and cell proliferation when the UBP1-TFCP2 binding motif is proximal to the TSS, but represses HIV-1 transcription (reinforcing viral latency) when the motif overlaps the TSS, by cooperatively binding the HIV-1 transcriptional start site and inhibiting preinitiation complex assembly.","method":"Protein purification coupled with mass spectrometry (MED16 identified as UBP1-TFCP2 binding partner), gene expression analysis, genomic-scale motif analysis, HIV-1 transcription assay","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — purification/MS identification of novel complex plus functional transcription assays; preprint, not yet peer-reviewed","pmids":["bio_10.1101_2025.08.12.669905"],"is_preprint":true}],"current_model":"UBP1 (LBP-1a/NF2d9) is a member of the TFCP2/Grainyhead family of transcription factors that requires heterodimerization with LBP-1b for nuclear localization; once nuclear, it represses HIV-1 transcription by blocking TFIID binding at the TATA element, represses IgA class switch recombination by directly occupying immunoglobulin switch regions, activates CYP11A/CYP2A8 transcription to regulate steroid biosynthesis and blood pressure, and is essential for extraembryonic angiogenesis in vivo; additionally, UBP1 forms a subcomplex with Mediator subunit MED16 and TFCP2 to exert context-dependent transcriptional activation or repression based on the positional relationship of its binding motif to the transcriptional start site."},"narrative":{"teleology":[{"year":1991,"claim":"The first mechanistic question—how host factors repress HIV-1 transcription—was answered by showing that LBP-1 (including UBP1/LBP-1a) directly competes with TFIID at the HIV-1 TATA element, establishing UBP1 as a transcriptional repressor operating through steric exclusion of the basal machinery.","evidence":"In vitro transcription, DNase I footprinting, gel shift, and site-directed mutagenesis in stable cell lines","pmids":["2006421"],"confidence":"High","gaps":["Identity and number of distinct LBP-1 polypeptides were unknown","Whether UBP1 could also activate transcription was not addressed","In vivo physiological relevance of HIV-1 repression was untested"]},{"year":1994,"claim":"Molecular cloning resolved the LBP-1 family into four alternatively spliced isoforms from two genes and revealed that UBP1 binds DNA as a multimer, can activate transcription in a promoter-context-dependent manner, and is subject to dominant-negative regulation by a truncated isoform.","evidence":"cDNA cloning, recombinant protein DNA-binding assays, cell-free transcription, and in vivo reporter assays","pmids":["8114710"],"confidence":"High","gaps":["How promoter context switches UBP1 from repressor to activator was undefined","No information on subcellular trafficking of individual isoforms","Physiological target genes beyond HIV-1 were unidentified"]},{"year":2000,"claim":"Identification of UBP1-family regulation of CYP11A1 (P450scc) in placenta showed that LBP-1b activates while the related factor LBP-9 suppresses this activation, establishing antagonistic family-member control over steroidogenic gene expression.","evidence":"Yeast one-hybrid/two-hybrid screens, RT-PCR, transient transfection reporter assays, antibody supershift","pmids":["10644752"],"confidence":"Medium","gaps":["Direct role of UBP1/LBP-1a itself (versus LBP-1b) at the CYP11A1 promoter was not resolved","In vivo steroidogenic consequences were not measured","Structural basis for antagonism between family members was unknown"]},{"year":2004,"claim":"Two contemporaneous studies expanded UBP1's target gene repertoire (CYP2A8 activation via PREX element binding) and, critically, demonstrated that UBP1 knockout in mice causes embryonic lethality by E11.5 from defective extraembryonic angiogenesis, establishing an essential developmental function.","evidence":"EMSA and reporter assays for CYP2A8; conditional KO mice with histology, immunohistochemistry, and tetraploid complementation for angiogenesis phenotype","pmids":["15282311","15716014"],"confidence":"High","gaps":["Downstream transcriptional targets mediating the angiogenic defect were not identified","Whether heterodimer composition determines tissue-specific functions was unexplored","No rescue experiment was performed to test sufficiency"]},{"year":2005,"claim":"The long-standing question of how UBP1 reaches its nuclear targets was resolved: UBP1 is cytosolic when expressed alone and depends on heterodimerization with LBP-1b (which harbors an NLS) for nuclear import, after which it localizes to PML body-associated speckles.","evidence":"YFP-fusion imaging and co-expression experiments in COS-7 cells with NLS mapping","pmids":["16115195"],"confidence":"Medium","gaps":["Functional significance of PML body colocalization was not determined","Whether endogenous LBP-1b availability limits UBP1 activity in vivo was untested","Post-translational modifications regulating the interaction were not explored"]},{"year":2009,"claim":"UBP1's role was extended to adaptive immunity: ChIP demonstrated direct occupancy of immunoglobulin switch regions Sμ and Sα in B cells, and loss-of-function in hematopoietic lineages enhanced IgA (but not IgG1) class switch recombination, establishing UBP1 as an isotype-specific repressor of CSR. Concurrently, QTL mapping linked the UBP1 locus to blood pressure in mice and humans via CYP11A-dependent steroid/aldosterone biosynthesis.","evidence":"ChIP in primary splenic B cells, bone marrow chimeric mice with CSR analysis; QTL mapping in BXD strains and human SNP association","pmids":["19384868","19662162"],"confidence":"High","gaps":["Mechanism by which UBP1 occupancy at switch regions blocks recombination was unclear","Causal variant at the human UBP1 locus affecting blood pressure was not pinpointed","Whether UBP1's angiogenic and steroidogenic roles converge in placental physiology was unexplored"]},{"year":2025,"claim":"A new subcomplex of MED16 (dissociated from core Mediator) with UBP1 and TFCP2 was identified, resolving how UBP1 exerts dual transcriptional effects: the complex activates genes when its binding motif is proximal to the TSS but represses HIV-1 transcription when the motif overlaps the TSS by blocking preinitiation complex assembly.","evidence":"Protein purification/mass spectrometry, gene expression analysis, genomic motif analysis, HIV-1 transcription assay (preprint)","pmids":["bio_10.1101_2025.08.12.669905"],"confidence":"Medium","gaps":["Preprint not yet peer-reviewed; awaits independent validation","Structural basis for motif-position-dependent switching between activation and repression is unresolved","Whether the MED16-UBP1-TFCP2 subcomplex operates in B cells or placental angiogenesis is untested"]},{"year":null,"claim":"Key unresolved questions include the identity of direct transcriptional targets mediating the embryonic angiogenic defect, the structural basis for the positional switch between activation and repression by the MED16-UBP1-TFCP2 complex, and the causal variants and tissue-specific mechanisms underlying the UBP1-blood pressure association in humans.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No transcriptome-wide target identification in the embryonic extraembryonic vasculature","No structural model for UBP1 or its complexes","Mechanism by which switch-region occupancy blocks CSR remains undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,4,6]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,2,4,6,8]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5,6]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,2,4,8]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[6]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,8]}],"complexes":["MED16-UBP1-TFCP2 subcomplex"],"partners":["LBP1B","TFCP2","MED16"],"other_free_text":[]},"mechanistic_narrative":"UBP1 (LBP-1a/NF2d9) is a TFCP2/Grainyhead-family transcription factor that functions as a context-dependent transcriptional activator or repressor. It binds DNA as a multimer and represses HIV-1 transcription by occluding the TATA element to block TFIID recruitment, and it directly occupies immunoglobulin switch regions to repress IgA class switch recombination in B lymphocytes [PMID:2006421, PMID:19384868]. UBP1 lacks its own nuclear localization signal and requires heterodimerization with the related factor LBP-1b for nuclear import, after which it accumulates in PML body-associated speckles [PMID:16115195]. Genetic ablation in mice causes embryonic lethality by E11.5 due to defective extraembryonic angiogenesis, and the UBP1 locus is a blood pressure determinant linked to transcriptional activation of the steroidogenic enzyme CYP11A [PMID:15282311, PMID:19662162]."},"prefetch_data":{"uniprot":{"accession":"Q9NZI7","full_name":"Upstream-binding protein 1","aliases":["Transcription factor LBP-1"],"length_aa":540,"mass_kda":60.5,"function":"Functions as a transcriptional activator in a promoter context-dependent manner. Modulates the placental expression of CYP11A1. Involved in regulation of the alpha-globin gene in erythroid cells. Activation of the alpha-globin promoter in erythroid cells is via synergistic interaction with TFCP2 (By similarity). Involved in regulation of the alpha-globin gene in erythroid cells. Binds strongly to sequences around the HIV-1 initiation site and weakly over the TATA-box. Represses HIV-1 transcription by inhibiting the binding of TFIID to the TATA-box","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9NZI7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/UBP1","classification":"Not Classified","n_dependent_lines":14,"n_total_lines":1208,"dependency_fraction":0.011589403973509934},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"PARP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/UBP1","total_profiled":1310},"omim":[{"mim_id":"609785","title":"TRANSCRIPTION FACTOR CP2-LIKE 1; TFCP2L1","url":"https://www.omim.org/entry/609785"},{"mim_id":"609784","title":"UPSTREAM BINDING PROTEIN 1; UBP1","url":"https://www.omim.org/entry/609784"},{"mim_id":"608985","title":"RING FINGER PROTEIN 2; RNF2","url":"https://www.omim.org/entry/608985"},{"mim_id":"606673","title":"BETA-UREIDOPROPIONASE; UPB1","url":"https://www.omim.org/entry/606673"},{"mim_id":"189889","title":"TRANSCRIPTION FACTOR CP2; TFCP2","url":"https://www.omim.org/entry/189889"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/UBP1"},"hgnc":{"alias_symbol":["LBP-1a"],"prev_symbol":[]},"alphafold":{"accession":"Q9NZI7","domains":[{"cath_id":"2.60.40","chopping":"65-274","consensus_level":"high","plddt":92.4339,"start":65,"end":274},{"cath_id":"3.10.20,3.10.20","chopping":"431-439_464-540","consensus_level":"high","plddt":91.095,"start":431,"end":540},{"cath_id":"1.10.150","chopping":"371-423","consensus_level":"high","plddt":91.2489,"start":371,"end":423}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NZI7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NZI7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NZI7-F1-predicted_aligned_error_v6.png","plddt_mean":74.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=UBP1","jax_strain_url":"https://www.jax.org/strain/search?query=UBP1"},"sequence":{"accession":"Q9NZI7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NZI7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NZI7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NZI7"}},"corpus_meta":[{"pmid":"3138113","id":"PMC_3138113","title":"Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.","date":"1988","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/3138113","citation_count":195,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2050695","id":"PMC_2050695","title":"Cloning and functional analysis of the ubiquitin-specific protease gene UBP1 of Saccharomyces cerevisiae.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2050695","citation_count":143,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10747031","id":"PMC_10747031","title":"UBP1, a novel hnRNP-like protein that functions at multiple steps of higher plant nuclear pre-mRNA maturation.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10747031","citation_count":92,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29410248","id":"PMC_29410248","title":"TFCP2/TFCP2L1/UBP1 transcription factors in cancer.","date":"2018","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/29410248","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12024044","id":"PMC_12024044","title":"UBA1 and UBA2, two proteins that interact with UBP1, a multifunctional effector of pre-mRNA maturation in plants.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12024044","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19662162","id":"PMC_19662162","title":"Identification of the UBP1 locus as a critical blood pressure determinant using a combination of mouse and human genetics.","date":"2009","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19662162","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15282311","id":"PMC_15282311","title":"Defective extraembryonic angiogenesis in mice lacking LBP-1a, a member of the grainyhead family of transcription factors.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15282311","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30241344","id":"PMC_30241344","title":"Neglected Functions of TFCP2/TFCP2L1/UBP1 Transcription Factors May Offer Valuable Insights into Their Mechanisms of Action.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30241344","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15635103","id":"PMC_15635103","title":"The deubiquitinating enzyme Ubp1 affects sorting of the ATP-binding cassette-transporter Ste6 in the endocytic pathway.","date":"2005","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15635103","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32340987","id":"PMC_32340987","title":"Experimentally Engineered Mutations in a Ubiquitin Hydrolase, UBP-1, Modulate In Vivo Susceptibility to Artemisinin and Chloroquine in Plasmodium berghei.","date":"2020","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/32340987","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38413566","id":"PMC_38413566","title":"Deaggregation of mutant Plasmodium yoelii de-ubiquitinase UBP1 alters MDR1 localization to confer multidrug resistance.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38413566","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15924623","id":"PMC_15924623","title":"Expression of yeast deubiquitination enzyme UBP1 analogues in E. coli.","date":"2005","source":"Microbial cell factories","url":"https://pubmed.ncbi.nlm.nih.gov/15924623","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16115195","id":"PMC_16115195","title":"Heterodimerization with LBP-1b is necessary for nuclear localization of LBP-1a and LBP-1c.","date":"2005","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/16115195","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25158991","id":"PMC_25158991","title":"Use of Ubp1 protease analog to produce recombinant human growth hormone in Escherichia coli.","date":"2014","source":"Microbial cell factories","url":"https://pubmed.ncbi.nlm.nih.gov/25158991","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24994500","id":"PMC_24994500","title":"A lack of association between polymorphisms of three positional candidate genes (CLASP2 , UBP1, and FBXL2) and canine disorder of sexual development (78,XX; SRY -negative).","date":"2014","source":"Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/24994500","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26096620","id":"PMC_26096620","title":"Association of UBP1 to ribonucleoprotein complexes is regulated by interaction with the trypanosome ortholog of the human multifunctional P32 protein.","date":"2015","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/26096620","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19384868","id":"PMC_19384868","title":"Binding of LBP-1a to specific immunoglobulin switch regions in vivo correlates with specific repression of class switch recombination.","date":"2009","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19384868","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34877752","id":"PMC_34877752","title":"Novel EWSR1::UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas.","date":"2021","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34877752","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15716014","id":"PMC_15716014","title":"Transcription factor NF2d9 (LBP-1a) interacts with the positive regulatory element for the xenobiotic responsive element.","date":"2004","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/15716014","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38758959","id":"PMC_38758959","title":"Transcriptomic analysis of N-terminal mutated Trypanosoma cruzi UBP1 knockdown underlines the importance of this RNA-binding protein in parasite development.","date":"2024","source":"PLoS neglected tropical diseases","url":"https://pubmed.ncbi.nlm.nih.gov/38758959","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39909372","id":"PMC_39909372","title":"Drug resistance-associated mutations in Plasmodium UBP-1 disrupt its essential deubiquitinating activity.","date":"2025","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39909372","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38348324","id":"PMC_38348324","title":"Proteomic data of the Trypanosoma cruzi insect-dwelling epimastigotes overexpressing the RNA-binding protein UBP1.","date":"2024","source":"Data in brief","url":"https://pubmed.ncbi.nlm.nih.gov/38348324","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8392872","id":"PMC_8392872","title":"Characterization of Ustilago maydis DNA binding protein one (UBP1).","date":"1993","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/8392872","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39964481","id":"PMC_39964481","title":"Ubiquitin protease Ubp1 cooperates with Ubp10 and Ubp12 to revert lysine-164 PCNA ubiquitylation at replication forks.","date":"2025","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/39964481","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38389957","id":"PMC_38389957","title":"RNA-seq data exploration after trypanosome RNA-binding protein UBP1 expression is altered by CRISPR-Cas9 gene editing and overexpression.","date":"2024","source":"Data in brief","url":"https://pubmed.ncbi.nlm.nih.gov/38389957","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.08.12.669905","title":"Mediator Subunit MED16 Collaborates with UBP1-TFCP2 to Control Transcriptional Activation or Repression via Promoter Positional Specificity","date":"2025-08-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.12.669905","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.10.27.620464","title":"Foxi1 regulates multipotent mucociliary progenitors and ionocyte specification through transcriptional and epigenetic mechanisms","date":"2024-10-27","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.27.620464","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19274049","id":"PMC_19274049","title":"A census of human transcription factors: function, expression and evolution.","date":"2009","source":"Nature reviews. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19274049","citation_count":1191,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28473536","id":"PMC_28473536","title":"Impact of cytosine methylation on DNA binding specificities of human transcription factors.","date":"2017","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/28473536","citation_count":934,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20211142","id":"PMC_20211142","title":"An atlas of combinatorial transcriptional regulation in mouse and man.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/20211142","citation_count":573,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21988832","id":"PMC_21988832","title":"Toward an understanding of the protein interaction network of the human liver.","date":"2011","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/21988832","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26673895","id":"PMC_26673895","title":"A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26673895","citation_count":198,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21653829","id":"PMC_21653829","title":"Protein interactome reveals converging molecular pathways among autism disorders.","date":"2011","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21653829","citation_count":180,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25544563","id":"PMC_25544563","title":"Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.","date":"2014","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/25544563","citation_count":173,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30804502","id":"PMC_30804502","title":"H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30804502","citation_count":162,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2006421","id":"PMC_2006421","title":"Repression of HIV-1 transcription by a cellular protein.","date":"1991","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/2006421","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19322201","id":"PMC_19322201","title":"Ubiquitin-mediated proteolysis of HuR by heat shock.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19322201","citation_count":142,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25609649","id":"PMC_25609649","title":"Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.","date":"2015","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/25609649","citation_count":120,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8114710","id":"PMC_8114710","title":"Characterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vitro.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8114710","citation_count":102,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30021884","id":"PMC_30021884","title":"Histone Interaction Landscapes Visualized by Crosslinking Mass Spectrometry in Intact Cell Nuclei.","date":"2018","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/30021884","citation_count":101,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35016035","id":"PMC_35016035","title":"Identification and functional characterization of transcriptional activators in human cells.","date":"2022","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/35016035","citation_count":98,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32694731","id":"PMC_32694731","title":"Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.","date":"2020","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32694731","citation_count":92,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10644752","id":"PMC_10644752","title":"Cloning of factors related to HIV-inducible LBP proteins that regulate steroidogenic factor-1-independent human placental transcription of the cholesterol side-chain cleavage enzyme, P450scc.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10644752","citation_count":68,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33106477","id":"PMC_33106477","title":"Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33106477","citation_count":63,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13569,"output_tokens":2658,"usd":0.040288},"stage2":{"model":"claude-opus-4-6","input_tokens":5967,"output_tokens":2665,"usd":0.14469},"total_usd":0.393621,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":25471,"output_tokens":3886,"usd":0.067351},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6314,"output_tokens":2505,"usd":0.141292}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"Yeast UBP1 encodes a ubiquitin-specific processing protease that cleaves at the carboxyl terminus of the ubiquitin moiety in natural and engineered ubiquitin fusion proteins, irrespective of their size, but is inactive on polyubiquitin chains. This distinguishes it from YUH1, which only deubiquitinates relatively short ubiquitin fusions.\",\n      \"method\": \"Cloning by sib selection, in vitro protease activity assays with ubiquitin-fusion substrates (including ubiquitin-beta-galactosidase), null mutant analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro enzymatic assay with multiple substrates, mutagenesis context, and genetic null mutant characterization\",\n      \"pmids\": [\"2050695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"UBP-1 (human/HeLa cell protein) is a 61–63 kDa cellular protein that binds specifically to the TAR region (sequences CTCTCTGG) of the HIV-1 LTR and also to the TATA region; mutations of the TAR regulatory region prevented binding. Purified by DNA affinity chromatography.\",\n      \"method\": \"DNA affinity chromatography purification, UV cross-linking, DNase I footprinting, gel mobility shift with mutant probes\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical purification with multiple orthogonal binding assays (UV cross-linking + DNase I footprinting) and mutational validation\",\n      \"pmids\": [\"3138113\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Yeast Ubp1 exists as two forms from the same gene: a longer membrane-anchored form (mUbp1) localizing to the ER membrane, and a shorter soluble form (sUbp1). Overexpression of sUbp1 stabilizes the ABC transporter Ste6 and causes its accumulation at the cell surface, suggesting Ubp1 targets a component of the endocytic transport machinery rather than directly deubiquitinating Ste6.\",\n      \"method\": \"Sucrose density gradient centrifugation, immunofluorescence microscopy, pulse-chase degradation assays, overexpression studies with WT and mutant substrates\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (localization + functional degradation assays) in a single lab study\",\n      \"pmids\": [\"15635103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"LBP-1a (UBP1/NF2d9) is required for extraembryonic angiogenesis; LBP-1a-null mice die at E11.5 due to failure of allantoic blood vessels to penetrate and branch into the placental labyrinth and failure of yolk sac capillaries to connect into a vascular network, without a primary trophoblast defect (demonstrated by tetraploid complementation).\",\n      \"method\": \"Knockout mouse generation, histological analysis, tetraploid complementation rescue experiments, trophoblast marker expression analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout with defined angiogenic phenotype, complementation controls exclude trophoblast-primary defect, multiple orthogonal methods\",\n      \"pmids\": [\"15282311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"LBP-1a (UBP1) is exclusively cytosolic when expressed alone; heterodimerization with LBP-1b (which contains a nuclear localization signal encoded by exon 6) is necessary for nuclear import of LBP-1a. In the nucleus, LBP-1a accumulates in PML bodies via its N-terminal region.\",\n      \"method\": \"YFP-fusion subcellular localization in COS-7 cells, co-expression experiments, deletion mapping of NLS and PML-body targeting domain\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization imaging with functional co-expression and domain mapping, single lab\",\n      \"pmids\": [\"16115195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NF2d9/LBP-1a (UBP1) binds directly to the PREX positive regulatory element upstream of the XRE in the CYP2A8 gene and indirectly interacts with XRE; overexpression of NF2d9 enhances PREX- and XRE-driven CYP2A8 transcriptional induction.\",\n      \"method\": \"Gel mobility shift assay (EMSA), luciferase reporter gene assays with overexpression\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, EMSA and reporter assay only, no mutagenesis or reciprocal ChIP\",\n      \"pmids\": [\"15716014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"LBP-1a (UBP1) binds genomic switch regions (Smu and Salpha but not Sgamma1) in primary mouse B cells in an isotype-specific manner, and its occupancy decreases dramatically after LPS stimulation; loss of LSF/LBP-1 activity in bone marrow chimeric mice leads to enhanced CSR specifically to IgA, demonstrating that LBP-1a represses class switch recombination in an isotype-specific manner.\",\n      \"method\": \"ChIP in primary B cells, bone marrow chimeric mice with inhibition of LSF/LBP-1 activity, in vitro B cell stimulation and CSR measurement\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with in vivo genetic loss-of-function model and isotype-specific phenotype, single lab\",\n      \"pmids\": [\"19384868\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"UBP1 (LBP-1a) plays a role in transcriptional activation of CYP11A, the rate-limiting enzyme in pregnenolone and aldosterone biosynthesis, thereby participating in cholesterol and steroid metabolism; genetic variants in the UBP1 locus associate with blood pressure in human populations.\",\n      \"method\": \"QTL mapping in BXD recombinant inbred mouse strains combined with human association studies; functional link to CYP11A transcriptional activation inferred from prior literature\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — genetic mapping study; the mechanistic link to CYP11A is referenced but not directly demonstrated in this paper\",\n      \"pmids\": [\"19662162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Yeast Ubp1 localizes to the nucleus and associates with DNA replication forks, where it deubiquitylates PCNA at lysine 164. Ubp1 cooperates with Ubp10 and Ubp12 to revert PCNAK164 ubiquitylation under unperturbed replication conditions; deletion of all three DUBs causes persistent PCNAK164 ubiquitylation and delayed S-phase progression.\",\n      \"method\": \"Genetic epistasis (triple deletion mutants), co-immunoprecipitation, in vitro deubiquitylation assay, chromatin immunoprecipitation at replication forks, flow cytometry for S-phase analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro deubiquitylation assay combined with genetic epistasis, ChIP at replication forks, and defined cell-cycle phenotype\",\n      \"pmids\": [\"39964481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MED16 dissociates from the core Mediator complex to form a subcomplex with UBP1 and TFCP2; the MED16-UBP1 interaction can activate or repress transcription depending on the position of the UBP1-TFCP2 binding motif relative to the TSS. Specifically, MED16 and UBP1 cooperatively bind the HIV-1 transcriptional start site to inhibit preinitiation complex assembly and reinforce viral latency.\",\n      \"method\": \"Protein purification coupled with mass spectrometry (identification of MED16 as UBP1 binding partner), gene expression analysis, genomic-scale motif-position analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mass spectrometry-based interaction discovery plus gene expression and genomic analyses; preprint, single lab\",\n      \"pmids\": [\"bio_10.1101_2025.08.12.669905\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"UBP1 (LBP-1a/NF2d9) is a grainyhead-family transcription factor that binds specific DNA elements (TAR region of HIV LTR, immunoglobulin switch regions, CYP gene regulatory elements) to activate or repress transcription in a context-dependent manner, requires heterodimerization with LBP-1b for nuclear import, forms a subcomplex with MED16 and TFCP2 to modulate preinitiation complex assembly, and is essential for extraembryonic angiogenesis in mice; its yeast ortholog Ubp1 is a ubiquitin-specific processing protease that deubiquitylates ubiquitin-fusion proteins and PCNA at K164 at replication forks to regulate DNA damage tolerance.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify each paper before extracting discoveries.\n\n**Classification:**\n\nThe query gene UBP1 in human context refers to \"Upstream Binding Protein 1\" (also known as LBP-1a, NF2d9), a member of the TFCP2/Grainyhead family of transcription factors.\n\n**KEEP papers (about human/mammalian UBP1/LBP-1a transcription factor):**\n- [4] TFCP2/TFCP2L1/UBP1 transcription factors in cancer — KEEP\n- [6] UBP1 locus as blood pressure determinant — KEEP\n- [7] LBP-1a mice lacking extraembryonic angiogenesis — KEEP\n- [8] Neglected Functions TFCP2/TFCP2L1/UBP1 — KEEP (review, limited mechanistic)\n- [13] Heterodimerization LBP-1b necessary for nuclear localization LBP-1a — KEEP\n- [17] LBP-1a binding to immunoglobulin switch regions — KEEP\n- [19] NF2d9 (LBP-1a) interacts with PREX — KEEP\n- [22] Repression of HIV-1 transcription by LBP-1 — KEEP\n- [25] Family of LBP-1 transcription factors modulate HIV-1 transcription — KEEP\n- [26] Preprint: MED16 collaborates with UBP1-TFCP2 — KEEP\n- [29] Cloning of LBP factors, P450scc transcription — KEEP\n\n**EXCLUDE papers:**\n- [1] EBP-1 and UBP-1 — different protein (TAR binding, HIV enhancer binding protein, unrelated to TFCP2 family UBP1) — EXCLUDE (alias collision)\n- [2] Yeast UBP1 ubiquitin-specific protease — SYMBOL COLLISION (yeast deubiquitinase, not transcription factor)\n- [3] Plant UBP1 hnRNP — SYMBOL COLLISION (plant protein)\n- [5] UBA1/UBA2 interact with plant UBP1 — SYMBOL COLLISION\n- [9] Yeast Ubp1 endocytic sorting — SYMBOL COLLISION\n- [10] Plasmodium UBP-1 artemisinin resistance — SYMBOL COLLISION\n- [11] Plasmodium yoelii UBP1 MDR1 — SYMBOL COLLISION\n- [12] Yeast UBP1 in E. coli expression — SYMBOL COLLISION\n- [14] UBP1 canine DSD — limited mechanistic, association study — EXCLUDE\n- [15] Canine DSD polymorphisms — EXCLUDE (association, no mechanism)\n- [16] Trypanosome TcUBP1 — SYMBOL COLLISION\n- [18] Novel EWSR1::UBP1 fusion sarcoma — EXCLUDE (fusion event description, no mechanism of UBP1 itself)\n- [20] Trypanosome UBP1 transcriptomic — SYMBOL COLLISION\n- [21] Plasmodium UBP-1 deubiquitinating — SYMBOL COLLISION\n- [22] — KEEP (LBP-1 represses HIV-1 transcription)\n- [23] Ustilago maydis UBP1 — SYMBOL COLLISION\n- [24] Yeast Ubp1 PCNA deubiquitylase — SYMBOL COLLISION\n- [25] — KEEP (LBP-1 family)\n- [27] Foxi1/Ubp1 Xenopus — need to check: mentions Ubp1 in cooperation with Foxi1 for ISC specification in Xenopus. This Ubp1 appears to be the transcription factor ortholog in Xenopus, consistent with TFCP2 family. KEEP cautiously, but mechanistic detail about UBP1 specifically is minimal.\n\n**Additional curated papers:**\n- [22 curated] Repression HIV-1 by LBP-1 — KEEP (same as retrieved [22])\n- [25 curated] LBP-1 family — KEEP (same as retrieved [25])\n- [29 curated] LBP factors P450scc — KEEP\n- Others (interactome databases, cDNA collections, general TF census) — EXCLUDE (no specific UBP1 mechanism)\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"LBP-1 (encompassing LBP-1a/UBP1) is a cellular DNA-binding protein that represses HIV-1 transcription in vitro by binding to a site (site II) overlapping the TATA element, thereby inhibiting TFIID binding. Pre-binding of TFIID blocks this repression. Mutations eliminating LBP-1 binding to site II abolished in vitro repression and increased HIV-1 transcription in stably transformed cells, demonstrating a direct mechanistic role in transcriptional repression resembling bacterial repressors.\",\n      \"method\": \"In vitro transcription assay, gel mobility shift, DNase I footprinting, site-directed mutagenesis, stable cell transfection\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis and cellular validation; multiple orthogonal methods\",\n      \"pmids\": [\"2006421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Four LBP-1 isoforms (LBP-1a, -b, -c, -d) encoded by two related genes via alternative splicing were characterized. LBP-1a (UBP1) and other isoforms bind DNA as multimers with identical specificity to native LBP-1, and specifically repress HIV-1 transcription in a cell-free system. One isoform lacking the Elf-1/NTF-1 homology region cannot bind DNA but acts as a dominant negative regulator by inhibiting other LBP-1 isoforms through heteromer formation. LBP-1 can also function as a transcriptional activator in a promoter-context-dependent manner both in vivo and in vitro.\",\n      \"method\": \"cDNA cloning, recombinant protein expression, DNA-binding assays, cell-free transcription system, in vivo reporter assays, antisera recognition\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including in vitro transcription, DNA binding, and in vivo assays; single lab but comprehensive\",\n      \"pmids\": [\"8114710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"LBP-1b and a newly identified related factor LBP-9 (sharing 83% amino acid identity with LBP-1b) both bind specifically to the -155/-131 region of the human P450scc (CYP11A1) promoter, which drives placental but not adrenal transcription. LBP-1b strongly activates P450scc transcription (21-fold) while LBP-9 suppresses this LBP-1b-mediated activation, demonstrating antagonistic roles of LBP family members in placental steroidogenesis.\",\n      \"method\": \"Yeast one-hybrid screen, yeast two-hybrid binding assay, RT-PCR, transient transfection reporter assays, antibody supershift\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal binding and functional reporter assays; single lab with multiple methods\",\n      \"pmids\": [\"10644752\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mice lacking LBP-1a (UBP1) develop intrauterine growth retardation by embryonic day 10.5 and die by E11.5, with a pronounced defect in extraembryonic angiogenesis: allantoic blood vessels fail to branch into the placental labyrinth, and yolk sac primary capillary tubes fail to connect into a vascular network. Tetraploid complementation excluded a primary trophoblast defect, placing the angiogenic defect as the primary cause of embryonic lethality.\",\n      \"method\": \"Conditional knockout mouse model, histology, immunohistochemistry, tetraploid complementation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined lethal phenotype, complementation experiments, multiple orthogonal readouts\",\n      \"pmids\": [\"15282311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NF2d9 (LBP-1a/UBP1), a transcription factor related to CP2/LBP-1c, binds directly to PREX (positive regulatory element for the xenobiotic responsive element) in the CYP2A8 gene and also interacts indirectly with XRE. Overexpression of NF2d9 enhances PREX- and XRE-driven CYP2A8 gene transcriptional induction.\",\n      \"method\": \"Gel mobility shift assay (EMSA), luciferase reporter gene assay, transient transfection\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct DNA binding demonstrated by EMSA plus functional reporter assay; single lab\",\n      \"pmids\": [\"15716014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"LBP-1a (UBP1) and LBP-1c are exclusively localized in the cytosol when expressed alone, whereas LBP-1b (which contains a nuclear localization signal encoded by exon 6) resides in the nucleus. Co-expression of LBP-1b with LBP-1a or LBP-1c enables nuclear transport of the latter, demonstrating that heterodimerization with LBP-1b is required for nuclear localization of UBP1/LBP-1a. In the nucleus, LBP-1 proteins form speckles that largely overlap with PML bodies, and the N-terminal region of LBP-1a mediates PML body accumulation.\",\n      \"method\": \"YFP fusion protein subcellular localization imaging in COS-7 cells, co-expression experiments, NLS mapping\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct live-cell imaging with functional consequence (nuclear entry dependent on heterodimerization); single lab\",\n      \"pmids\": [\"16115195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"LBP-1a (UBP1) is the predominant LBP/LSF family member expressed in B lymphocytes. ChIP analysis demonstrates that LBP-1a binds genomic sequences around the immunoglobulin switch regions Smu and Salpha (but not Sgamma1) in an isotype-specific manner in primary mouse splenic B cells, and this binding is dynamically regulated (occupancy decreases after LPS stimulation). Using bone marrow chimeric mice with inhibited LSF/LBP-1 activity in hematopoietic lineages, CSR to IgA (but not IgG1) was enhanced, demonstrating that LBP-1a directly represses class switch recombination in an isotype-specific manner.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), bone marrow chimeric mouse model, in vitro B cell stimulation, CSR analysis\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP showing direct genomic occupancy, complemented by in vivo loss-of-function with isotype-specific phenotypic readout\",\n      \"pmids\": [\"19384868\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The UBP1 locus was identified as a blood pressure determinant in mice and humans. UBP1 plays a role in cholesterol and steroid metabolism through transcriptional activation of CYP11A (the rate-limiting enzyme in pregnenolone and aldosterone biosynthesis), implicating UBP1 and its functional partners in a network controlling blood pressure.\",\n      \"method\": \"QTL mapping in BXD recombinant inbred mouse strains, human genetic association study (SNP analysis), functional annotation of CYP11A transcriptional regulation\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — genetic mapping combined with prior functional data on CYP11A transcriptional activation; mechanistic link inferred rather than directly demonstrated in this paper\",\n      \"pmids\": [\"19662162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MED16, a Mediator subunit, dissociates from the core Mediator complex to form a subcomplex with transcription factors UBP1 and TFCP2. This MED16-UBP1 interaction modulates transcription in a context-dependent (dual) manner: it activates genes involved in lung homeostasis, angiogenesis, and cell proliferation when the UBP1-TFCP2 binding motif is proximal to the TSS, but represses HIV-1 transcription (reinforcing viral latency) when the motif overlaps the TSS, by cooperatively binding the HIV-1 transcriptional start site and inhibiting preinitiation complex assembly.\",\n      \"method\": \"Protein purification coupled with mass spectrometry (MED16 identified as UBP1-TFCP2 binding partner), gene expression analysis, genomic-scale motif analysis, HIV-1 transcription assay\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — purification/MS identification of novel complex plus functional transcription assays; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.08.12.669905\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"UBP1 (LBP-1a/NF2d9) is a member of the TFCP2/Grainyhead family of transcription factors that requires heterodimerization with LBP-1b for nuclear localization; once nuclear, it represses HIV-1 transcription by blocking TFIID binding at the TATA element, represses IgA class switch recombination by directly occupying immunoglobulin switch regions, activates CYP11A/CYP2A8 transcription to regulate steroid biosynthesis and blood pressure, and is essential for extraembryonic angiogenesis in vivo; additionally, UBP1 forms a subcomplex with Mediator subunit MED16 and TFCP2 to exert context-dependent transcriptional activation or repression based on the positional relationship of its binding motif to the transcriptional start site.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"UBP1 (also called LBP-1a/NF2d9) is a grainyhead-family transcription factor that binds specific DNA regulatory elements—including the HIV-1 LTR TAR/TATA region, immunoglobulin switch regions, and CYP gene upstream elements—to activate or repress transcription in a context- and locus-dependent manner [PMID:3138113, PMID:19384868, PMID:15716014]. UBP1 requires heterodimerization with LBP-1b for nuclear import and accumulates in PML bodies once in the nucleus; it forms a subcomplex with MED16 and TFCP2 that modulates preinitiation complex assembly, with transcriptional outcome depending on binding-site position relative to the TSS [PMID:16115195]. UBP1 is essential for extraembryonic angiogenesis in mice, as null embryos die at E11.5 from failure of allantoic vessel invasion into the placental labyrinth and defective yolk sac vascular remodeling [PMID:15282311]. Its S. cerevisiae ortholog Ubp1 is a ubiquitin-specific processing protease that cleaves ubiquitin from fusion proteins and deubiquitylates PCNA at K164 at replication forks, cooperating with Ubp10 and Ubp12 to regulate DNA damage tolerance and S-phase progression [PMID:2050695, PMID:39964481].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Identification of UBP-1 as a sequence-specific DNA-binding protein recognizing the HIV-1 LTR TAR region established that a host factor directly engages the viral regulatory element, opening the question of its transcriptional role.\",\n      \"evidence\": \"DNA affinity chromatography purification from HeLa cells, UV cross-linking, DNase I footprinting, gel shift with mutant probes\",\n      \"pmids\": [\"3138113\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Functional consequence of TAR binding on HIV transcription not tested\",\n        \"Identity of the protein (gene cloning) not yet achieved\",\n        \"Whether binding occurs in vivo (no ChIP)\"\n      ]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Cloning of yeast UBP1 revealed it encodes a ubiquitin-specific processing protease that cleaves ubiquitin from fusion proteins but not polyubiquitin chains, establishing the first enzymatic activity for the UBP family.\",\n      \"evidence\": \"Cloning by sib selection in S. cerevisiae, in vitro protease assays with ubiquitin–β-galactosidase fusions, null mutant analysis\",\n      \"pmids\": [\"2050695\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Physiological substrates in vivo unknown\",\n        \"Relationship between yeast Ubp1 protease and human UBP-1 transcription factor unclear\"\n      ]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Knockout of LBP-1a (UBP1) in mice demonstrated that it is essential for extraembryonic angiogenesis, specifying that the transcription factor acts in the mesodermal vascular compartment rather than trophoblast.\",\n      \"evidence\": \"Gene-targeted null mice with E11.5 lethality, histological analysis, tetraploid complementation excluding trophoblast-primary defect\",\n      \"pmids\": [\"15282311\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct transcriptional targets mediating angiogenesis not identified\",\n        \"Whether UBP1 functions cell-autonomously in endothelial cells not resolved\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstration that UBP1 is cytosolic alone and requires heterodimerization with LBP-1b for nuclear entry explained how an obligate heterodimer architecture gates its transcriptional activity; PML body accumulation pointed to subnuclear compartmentalization.\",\n      \"evidence\": \"YFP-fusion imaging in COS-7 cells with co-expression and deletion mapping of NLS and PML-body targeting domains\",\n      \"pmids\": [\"16115195\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional significance of PML body localization not determined\",\n        \"Whether heterodimerization is regulated under physiological conditions unknown\",\n        \"Single cell line, no in vivo validation\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Discovery that yeast Ubp1 exists as membrane-anchored (ER) and soluble isoforms, with the soluble form stabilizing the ABC transporter Ste6, revealed a role in regulating endocytic transport—distinct from its known protease activity on ubiquitin fusions.\",\n      \"evidence\": \"Sucrose gradient fractionation, immunofluorescence, pulse-chase degradation assays in S. cerevisiae\",\n      \"pmids\": [\"15635103\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct deubiquitylation substrate in the endocytic pathway not identified\",\n        \"Whether ER-anchored form has a distinct function unknown\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"ChIP and bone marrow chimeric experiments showed that UBP1 occupies immunoglobulin switch regions (Sμ, Sα) in resting B cells and represses class switch recombination to IgA in an isotype-specific manner, extending its role from viral gene regulation to adaptive immune gene rearrangement.\",\n      \"evidence\": \"ChIP in primary mouse B cells, bone marrow chimeric mice with LSF/LBP-1 loss of function, CSR quantification\",\n      \"pmids\": [\"19384868\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which UBP1 binding to switch regions inhibits CSR not defined\",\n        \"Whether UBP1 directly prevents AID access or alters chromatin state unknown\",\n        \"Loss-of-function used a dominant-negative affecting the entire LSF/LBP-1 family, not UBP1-specific\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identification of PCNA-K164 as a direct substrate of yeast Ubp1 at replication forks, acting cooperatively with Ubp10 and Ubp12, resolved which DUBs reset PCNA ubiquitylation under unperturbed replication and linked Ubp1 to S-phase progression.\",\n      \"evidence\": \"In vitro deubiquitylation assay, ChIP at replication forks, triple-DUB deletion mutants, flow cytometry in S. cerevisiae\",\n      \"pmids\": [\"39964481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Relative contribution of Ubp1 versus Ubp10 and Ubp12 at individual forks not quantified\",\n        \"Whether Ubp1 deubiquitylates mono- versus polyubiquitylated PCNA with different efficiency unknown\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery that MED16 dissociates from core Mediator to form a subcomplex with UBP1 and TFCP2, which activates or represses transcription depending on motif position relative to the TSS, provided a mechanistic framework for UBP1's dual transcriptional output—including reinforcement of HIV-1 latency.\",\n      \"evidence\": \"Protein purification/mass spectrometry, gene expression profiling, genomic motif-position analysis (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.08.12.669905\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Preprint; not yet peer-reviewed\",\n        \"Structural basis of the MED16–UBP1–TFCP2 subcomplex not determined\",\n        \"Whether MED16 dissociation from Mediator is regulated or constitutive is unclear\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct transcriptional targets of UBP1 that mediate its essential role in extraembryonic angiogenesis remain unidentified, and whether the MED16–UBP1–TFCP2 subcomplex operates at vascular gene loci in vivo has not been tested.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No genome-wide target identification (ChIP-seq) for UBP1 in vascular or placental tissues\",\n        \"Relationship between UBP1's transcriptional and potential deubiquitylation-related functions in mammals unresolved\",\n        \"No structural information for UBP1 or its heterodimers\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 5, 6]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [3, 5, 6, 9]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 8]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 5, 6, 9]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 8]}\n    ],\n    \"complexes\": [\n      \"MED16–UBP1–TFCP2 subcomplex\",\n      \"LBP-1a/LBP-1b heterodimer\"\n    ],\n    \"partners\": [\n      \"TFCP2\",\n      \"MED16\",\n      \"PCNA\",\n      \"UBP10\",\n      \"UBP12\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"UBP1 (LBP-1a/NF2d9) is a TFCP2/Grainyhead-family transcription factor that functions as a context-dependent transcriptional activator or repressor. It binds DNA as a multimer and represses HIV-1 transcription by occluding the TATA element to block TFIID recruitment, and it directly occupies immunoglobulin switch regions to repress IgA class switch recombination in B lymphocytes [PMID:2006421, PMID:19384868]. UBP1 lacks its own nuclear localization signal and requires heterodimerization with the related factor LBP-1b for nuclear import, after which it accumulates in PML body-associated speckles [PMID:16115195]. Genetic ablation in mice causes embryonic lethality by E11.5 due to defective extraembryonic angiogenesis, and the UBP1 locus is a blood pressure determinant linked to transcriptional activation of the steroidogenic enzyme CYP11A [PMID:15282311, PMID:19662162].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"The first mechanistic question—how host factors repress HIV-1 transcription—was answered by showing that LBP-1 (including UBP1/LBP-1a) directly competes with TFIID at the HIV-1 TATA element, establishing UBP1 as a transcriptional repressor operating through steric exclusion of the basal machinery.\",\n      \"evidence\": \"In vitro transcription, DNase I footprinting, gel shift, and site-directed mutagenesis in stable cell lines\",\n      \"pmids\": [\"2006421\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity and number of distinct LBP-1 polypeptides were unknown\",\n        \"Whether UBP1 could also activate transcription was not addressed\",\n        \"In vivo physiological relevance of HIV-1 repression was untested\"\n      ]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Molecular cloning resolved the LBP-1 family into four alternatively spliced isoforms from two genes and revealed that UBP1 binds DNA as a multimer, can activate transcription in a promoter-context-dependent manner, and is subject to dominant-negative regulation by a truncated isoform.\",\n      \"evidence\": \"cDNA cloning, recombinant protein DNA-binding assays, cell-free transcription, and in vivo reporter assays\",\n      \"pmids\": [\"8114710\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How promoter context switches UBP1 from repressor to activator was undefined\",\n        \"No information on subcellular trafficking of individual isoforms\",\n        \"Physiological target genes beyond HIV-1 were unidentified\"\n      ]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of UBP1-family regulation of CYP11A1 (P450scc) in placenta showed that LBP-1b activates while the related factor LBP-9 suppresses this activation, establishing antagonistic family-member control over steroidogenic gene expression.\",\n      \"evidence\": \"Yeast one-hybrid/two-hybrid screens, RT-PCR, transient transfection reporter assays, antibody supershift\",\n      \"pmids\": [\"10644752\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct role of UBP1/LBP-1a itself (versus LBP-1b) at the CYP11A1 promoter was not resolved\",\n        \"In vivo steroidogenic consequences were not measured\",\n        \"Structural basis for antagonism between family members was unknown\"\n      ]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Two contemporaneous studies expanded UBP1's target gene repertoire (CYP2A8 activation via PREX element binding) and, critically, demonstrated that UBP1 knockout in mice causes embryonic lethality by E11.5 from defective extraembryonic angiogenesis, establishing an essential developmental function.\",\n      \"evidence\": \"EMSA and reporter assays for CYP2A8; conditional KO mice with histology, immunohistochemistry, and tetraploid complementation for angiogenesis phenotype\",\n      \"pmids\": [\"15282311\", \"15716014\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Downstream transcriptional targets mediating the angiogenic defect were not identified\",\n        \"Whether heterodimer composition determines tissue-specific functions was unexplored\",\n        \"No rescue experiment was performed to test sufficiency\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The long-standing question of how UBP1 reaches its nuclear targets was resolved: UBP1 is cytosolic when expressed alone and depends on heterodimerization with LBP-1b (which harbors an NLS) for nuclear import, after which it localizes to PML body-associated speckles.\",\n      \"evidence\": \"YFP-fusion imaging and co-expression experiments in COS-7 cells with NLS mapping\",\n      \"pmids\": [\"16115195\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional significance of PML body colocalization was not determined\",\n        \"Whether endogenous LBP-1b availability limits UBP1 activity in vivo was untested\",\n        \"Post-translational modifications regulating the interaction were not explored\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"UBP1's role was extended to adaptive immunity: ChIP demonstrated direct occupancy of immunoglobulin switch regions Sμ and Sα in B cells, and loss-of-function in hematopoietic lineages enhanced IgA (but not IgG1) class switch recombination, establishing UBP1 as an isotype-specific repressor of CSR. Concurrently, QTL mapping linked the UBP1 locus to blood pressure in mice and humans via CYP11A-dependent steroid/aldosterone biosynthesis.\",\n      \"evidence\": \"ChIP in primary splenic B cells, bone marrow chimeric mice with CSR analysis; QTL mapping in BXD strains and human SNP association\",\n      \"pmids\": [\"19384868\", \"19662162\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which UBP1 occupancy at switch regions blocks recombination was unclear\",\n        \"Causal variant at the human UBP1 locus affecting blood pressure was not pinpointed\",\n        \"Whether UBP1's angiogenic and steroidogenic roles converge in placental physiology was unexplored\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"A new subcomplex of MED16 (dissociated from core Mediator) with UBP1 and TFCP2 was identified, resolving how UBP1 exerts dual transcriptional effects: the complex activates genes when its binding motif is proximal to the TSS but represses HIV-1 transcription when the motif overlaps the TSS by blocking preinitiation complex assembly.\",\n      \"evidence\": \"Protein purification/mass spectrometry, gene expression analysis, genomic motif analysis, HIV-1 transcription assay (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.08.12.669905\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Preprint not yet peer-reviewed; awaits independent validation\",\n        \"Structural basis for motif-position-dependent switching between activation and repression is unresolved\",\n        \"Whether the MED16-UBP1-TFCP2 subcomplex operates in B cells or placental angiogenesis is untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of direct transcriptional targets mediating the embryonic angiogenic defect, the structural basis for the positional switch between activation and repression by the MED16-UBP1-TFCP2 complex, and the causal variants and tissue-specific mechanisms underlying the UBP1-blood pressure association in humans.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No transcriptome-wide target identification in the embryonic extraembryonic vasculature\",\n        \"No structural model for UBP1 or its complexes\",\n        \"Mechanism by which switch-region occupancy blocks CSR remains undefined\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 4, 6]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 2, 4, 6, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 2, 4, 8]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 8]}\n    ],\n    \"complexes\": [\n      \"MED16-UBP1-TFCP2 subcomplex\"\n    ],\n    \"partners\": [\n      \"LBP1B\",\n      \"TFCP2\",\n      \"MED16\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}